Bergstrand, MP; Helander, A; Hansson, T; Beck, O. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays Drug Test. Anal., 1 Apr 2017, 9 (4), 640-645. 522 kB. https://doi.org/10.1002/dta.2003
Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method Drug Test. Anal., 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657 LC,MS
Currie, KS. Antianxiety Agents In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #6
Noggle, FT; Clark, CR. Identification of some benzodiazepines of forensic interest J. Assoc. Off. Anal. Chem., , 62 (4), 799–807. 259 kB. #4 LC,IR,UV
Angelos, SA; Janovsky, TJ; Raney, JK. The identification and quantitation of pharmaceutical preparations by nuclear magnetic resonance spectroscopy J. Forensic Sci., 1 Mar 1991, 36 (2), 358–365. 383 kB. https://doi.org/10.1520/JFS13038J #Oxazepam NMR